Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
The standard protocol uses 2.8 mg per injection: 2 mg GHK-Cu + 400 mcg of BPC-157 + 400 mcg of TB-4
Typically 2.8 mg per day (2 mg GHK-Cu plus 0.4 mg each of BPC-157 and TB-4)
Preliminary studies suggest potential associations between 5-Amino-1MQ and mitochondrial outcomes, including investigations of biogenesis and cellular energy-related mechanisms
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
US$ 29.34
US$ 23.40
US$ 28.94
US$ 25.93
US$ 25.60
